These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 8009561

  • 1. Phenytoin age-dose-concentration relationship in children.
    Suzuki Y, Mimaki T, Cox S, Koepke J, Hayes J, Walson PD.
    Ther Drug Monit; 1994 Apr; 16(2):145-50. PubMed ID: 8009561
    [Abstract] [Full Text] [Related]

  • 2. Phenytoin Michaelis-Menten pharmacokinetics in Saudi patients.
    el-Sayed YM, Islam SI.
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):173-8. PubMed ID: 2714918
    [Abstract] [Full Text] [Related]

  • 3. Phenytoin dosage adjustment in Saudi epileptics: utilization of steady-state pharmacokinetic parameters.
    Abduljabbar M, Al-Khamis K, Ogunniyi A, Daif AK, Al-Yamani M.
    Eur J Neurol; 1999 May; 6(3):331-4. PubMed ID: 10210914
    [Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetics of phenytoin in Japanese patients with epilepsy: analysis with a dose-dependent clearance model.
    Odani A, Hashimoto Y, Takayanagi K, Otsuki Y, Koue T, Takano M, Yasuhara M, Hattori H, Furusho K, Inui K.
    Biol Pharm Bull; 1996 Mar; 19(3):444-8. PubMed ID: 8924916
    [Abstract] [Full Text] [Related]

  • 5. Three Michaelis-Menten pharmacokinetic dosing methods compared with physician dosing of phenytoin in an outpatient neurology practice.
    Spruill WJ, Wade WE, Cobb HH, Akbari S.
    Pharmacotherapy; 2001 Nov; 21(11):1407-14. PubMed ID: 11714214
    [Abstract] [Full Text] [Related]

  • 6. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
    Koren G, Brand N, MacLeod SM.
    Ther Drug Monit; 1984 Nov; 6(1):11-4. PubMed ID: 6710554
    [Abstract] [Full Text] [Related]

  • 7. Apparent Michaelis-Menten kinetic parameters of phenytoin in pediatric patients.
    Chiba K, Ishizaki T, Miura H, Minagawa K.
    Pediatr Pharmacol (New York); 1980 Nov; 1(2):171-80. PubMed ID: 7346739
    [Abstract] [Full Text] [Related]

  • 8. Estimation of Phenytoin Pharmacokinetic Parameters in Saudi Epileptic Patients.
    Alqahtani S, Alzaidi T, Alotaibi M, Alsultan A.
    Pharmacology; 2019 Nov; 104(1-2):60-66. PubMed ID: 31067540
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of phenytoin in children with acute neurotrauma.
    O'Mara NB, Jones PR, Anglin DL, Cox S, Nahata MC.
    Crit Care Med; 1995 Aug; 23(8):1418-24. PubMed ID: 7634814
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Graphic estimation of phenytoin dose in adults and children.
    Armijo JA, Cavada E.
    Ther Drug Monit; 1991 Nov; 13(6):507-10. PubMed ID: 1771648
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data.
    Battino D, Croci D, Mamoli D, Messina S, Perucca E.
    Epilepsy Res; 2004 Nov; 59(2-3):155-65. PubMed ID: 15246117
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.